Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients
- 572 Downloads
Emerging evidences indicate that inflammation plays a crucial role in carcinogenesis and tumor progression. Inflammatory response biomarkers are recognized as promising prognostic factors for improving predictive accuracy in renal cell carcinoma (RCC). We aimed to evaluate the prognostic significance of preoperative neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR) and serum C-reactive protein (CRP) in RCC.
484 surgical RCC patients were enrolled from 2006 to 2010 in this study. Receiver operating curve (ROC) was applied to assess the optimal cutoff levels for four biomarkers, and the prognostic values were determined by Kaplan–Meier curve, univariate and multivariate COX regression models. The predictive accuracy was evaluated by concordance index (c-index).
The median follow-up duration after surgical resection was 36 months. The optimal cutoff levels were 2.78 for NLR, 2.05 for dNLR, 185 for PLR and 5.1 for CRP by ROC curves analysis. Elevated NLR, dNLR, PLR and CRP were significantly correlated with worse overall survival (OS). Multivariate analysis showed that elevated NLR was an independent risk factor for OS, and NLR was superior to dNLR, PLR and CRP based on hazard ratio (HR 2.10, 95 % CI 1.21–3.64, P = 0.008). Additionally, the nomogram could more effectively work in predicting OS (c-index: 0.749) in surgical RCC patients.
Pre-operation NLR can be considered as a potential prognostic biomarker in patients with RCC who underwent surgical resection.
KeywordsNeutrophil-to-lymphocyte ratio Renal cell carcinoma Survival Prognosis
MA and XIE developed the protocol; XIA, YAO and ZHENG collected the data; WU and XIA analyzed the data; HU and XIA wrote and edited the manuscript; and HU supervised the project.
Compliance with ethical standards
Conflict of interest
The study was approved by Medical Ethics Committee of Jiangyin People’s Hospital, Hangzhou First People’s Hospital and Zhejiang Cancer Hospital, respectively.
- 9.Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ et al (2008) Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 34(1):55–60. doi: 10.1016/j.ejso.2007.02.014 CrossRefPubMedGoogle Scholar
- 10.Al Murri AM, Wilson C, Lannigan A, Doughty JC, Angerson WJ, McArdle CS et al (2007) Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer. Br J Cancer 96(6):891–895. doi: 10.1038/sj.bjc.6603682 CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Szkandera J, Gerger A, Liegl-Atzwanger B, Absenger G, Stotz M, Friesenbichler J et al (2014) The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer 135(2):362–370. doi: 10.1002/ijc.28677 CrossRefPubMedGoogle Scholar
- 14.Lamb GW, Aitchison M, Ramsey S, Housley SL, McMillan DC (2012) Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems. Br J Cancer 106(2):279–283. doi: 10.1038/bjc.2011.556 CrossRefPubMedGoogle Scholar
- 18.Yasuda Y, Saito K, Yuasa T, Kitsukawa S, Urakami S, Yamamoto S et al (2013) Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Int J Clin Oncol 18(5):884–889. doi: 10.1007/s10147-012-0454-0 CrossRefPubMedGoogle Scholar
- 19.Park YH, Ku JH, Kwak C, Kim HH (2014) Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy. Springerplus 3:243. doi: 10.1186/2193-1801-3-243 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Manola J, Royston P, Elson P, McCormack JB, Mazumdar M, Negrier S et al (2011) Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group. Clin Cancer Res 17(16):5443–5450. doi: 10.1158/1078-0432.CCR-11-0553 CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Dalpiaz O, Pichler M, Mannweiler S, Martin Hernandez JM, Stojakovic T, Pummer K et al (2014) Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. Br J Cancer 110(10):2531–2536. doi: 10.1038/bjc.2014.180 CrossRefPubMedPubMedCentralGoogle Scholar